suPAR-GUIDED ANAKINRA TREATMENT FOR VALIDATION OF THE RISK AND EARLY MANAGEMENT OF SEVERE RESPIRATORY FAILURE BY COVID-19:
THE SAVE-MORE DOUBLE-BLIND, RANDOMIZED, PHASE III CONFIRMATORY TRIAL

HOME PAGE

Centers in Greece: Please select your hospital and department from below

 

Centers in Italy: Please select your hospital and department from below

Important Notice

The SAVE-MORE trial has come to a successful conclusion.
The database has been locked and any reporting (addtions/deletion/updates) of events has been disabled.
Users are only able to view the patients' data from their centers.
We wish to express our gratitude for the fruitful collaboration to all the primary investigators, unblinded pharmacists, blinded physicians and monitors.
Best wishes.